JW-1-283 inhibits melanoma tumor growth via stabilization of the p53 pathway
Xie, Yang, Hou, Ruida, Hartman, Kelli L., Jiang, Jianxiong, Wu, Zhongzhi, Li, Wei
Published in Genes & diseases (01.05.2024)
Published in Genes & diseases (01.05.2024)
Get full text
Journal Article
Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis
Krutilina, Raisa I, Hartman, Kelli L, Oluwalana, Damilola, Playa, Hilaire C, Parke, Deanna N, Chen, Hao, Miller, Duane D, Li, Wei, Seagroves, Tiffany N
Published in Cancers (29.10.2022)
Published in Cancers (29.10.2022)
Get full text
Journal Article
SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis
Deng, Shanshan, Banerjee, Souvik, Chen, Hao, Pochampally, Satyanarayana, Wang, Yuxi, Yun, Mi-Kyung, White, Stephen W., Parmar, Keyur, Meibohm, Bernd, Hartman, Kelli L., Wu, Zhongzhi, Miller, Duane D., Li, Wei
Published in Cancer letters (28.02.2023)
Published in Cancer letters (28.02.2023)
Get full text
Journal Article
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer
Deng, Shanshan, Krutilina, Raisa I, Hartman, Kelli L, Chen, Hao, Parke, Deanna N, Wang, Rui, Mahmud, Foyez, Ma, Dejian, Lukka, Pradeep B, Meibohm, Bernd, Seagroves, Tiffany N, Miller, Duane D, Li, Wei
Published in Molecular cancer therapeutics (05.07.2022)
Published in Molecular cancer therapeutics (05.07.2022)
Get full text
Journal Article
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo
Pochampally, Satyanarayana, Hartman, Kelli L., Wang, Rui, Wang, Jiaxing, Yun, Mi-Kyung, Parmar, Keyur, Park, Hyunseo, Meibohm, Bernd, White, Stephen W., Li, Wei, Miller, Duane D.
Published in ACS pharmacology & translational science (14.04.2023)
Published in ACS pharmacology & translational science (14.04.2023)
Get full text
Journal Article
Abstract 1670: Sabizabulin shows anti-cancer efficacy in HER2+ breast cancer and novel sabizabulin derivatives overcome paclitaxel-resistance in triple negative breast cancer
Hartman, Kelli L., Krutilina, Raisa I., Oluwalana, Damilola, Parke, Deanna N., Chen, Hao, Miller, Duane D., Li, Wei, Seagroves, Tiffany N.
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article